|
|
Volumn 11, Issue 1, 2004, Pages 35-37
|
|
Current status of CDC lipid standardization and international needs for standardization in epidemiological studies and clinical trials in Japan
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
LIPID;
ATHEROSCLEROSIS;
CHEMICAL INDUSTRY;
CHOLESTEROL BLOOD LEVEL;
CLINICAL LABORATORY;
COST;
ELECTROPHORESIS;
ENZYME ASSAY;
FERMENTATION;
HUMAN;
HYDROLYSIS;
LETTER;
LIPID BLOOD LEVEL;
PRECIPITATION;
QUALITY CONTROL;
RISK FACTOR;
SEROEPIDEMIOLOGY;
STANDARDIZATION;
BLOOD;
CLINICAL TRIAL;
EPIDEMIOLOGY;
INTERNATIONAL COOPERATION;
JAPAN;
LABORATORY;
MEDICAL SOCIETY;
PUBLIC HEALTH SERVICE;
STANDARD;
UNITED STATES;
CLINICAL TRIAL (TOPIC);
STANDARDS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
CLINICAL TRIALS;
EPIDEMIOLOGIC STUDIES;
HUMANS;
INTERNATIONAL COOPERATION;
JAPAN;
LABORATORIES;
LIPIDS;
REFERENCE STANDARDS;
SOCIETIES, MEDICAL;
UNITED STATES;
CLINICAL TRIALS AS TOPIC;
|
|
EID: 85061478540
PISSN: 13403478
EISSN: 18803873
Source Type: Journal
DOI: 10.5551/JAT.11.35 Document Type: Letter |
|
Times cited : (7)
|
|
References (0)
|